These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18080333)

  • 1. GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2008 Jun; 100(2):387-96. PubMed ID: 18080333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
    Hui EK; Boado RJ; Pardridge WM
    Mol Pharm; 2009; 6(5):1536-43. PubMed ID: 19624167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Aug; 97(6):1376-86. PubMed ID: 17286273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse.
    Boado RJ; Hui EK; Lu JZ; Pardridge WM
    J Pharmacol Exp Ther; 2010 Jun; 333(3):961-9. PubMed ID: 20233799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.
    Boado RJ
    Drug News Perspect; 2008 Nov; 21(9):489-503. PubMed ID: 19180267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2008 Feb; 99(2):475-84. PubMed ID: 17680664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic engineering of a bifunctional IgG fusion protein with iduronate-2-sulfatase.
    Lu JZ; Hui EK; Boado RJ; Pardridge WM
    Bioconjug Chem; 2010 Jan; 21(1):151-6. PubMed ID: 20000684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein.
    Fu A; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Brain Res; 2010 Nov; 1360():193-7. PubMed ID: 20833153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of blood-brain barrier transport of glial-derived neurotrophic factor (GDNF) and an IgG-GDNF fusion protein in the rhesus monkey.
    Boado RJ; Pardridge WM
    Drug Metab Dispos; 2009 Dec; 37(12):2299-304. PubMed ID: 19741036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.
    Pardridge WM; Boado RJ
    Pharm Res; 2009 Oct; 26(10):2227-36. PubMed ID: 19609743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies.
    Zhou QH; Boado RJ; Pardridge WM
    J Drug Target; 2012 Sep; 20(8):715-9. PubMed ID: 22845843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter.
    Xia CF; Boado RJ; Zhang Y; Chu C; Pardridge WM
    J Gene Med; 2008 Mar; 10(3):306-15. PubMed ID: 18085726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Drug Metab Dispos; 2010 Apr; 38(4):566-72. PubMed ID: 20075191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHO cell expression, long-term stability, and primate pharmacokinetics and brain uptake of an IgG-paroxonase-1 fusion protein.
    Boado RJ; Hui EK; Lu JZ; Pardridge WM
    Biotechnol Bioeng; 2011 Jan; 108(1):186-96. PubMed ID: 20803562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection in stroke in the mouse with intravenous erythropoietin-Trojan horse fusion protein.
    Fu A; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Brain Res; 2011 Jan; 1369():203-7. PubMed ID: 21047502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insect GDNF:TTC fusion protein improves delivery of GDNF to mouse CNS.
    Li J; Chian RJ; Ay I; Kashi BB; Celia SA; Tamrazian E; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Biochem Biophys Res Commun; 2009 Dec; 390(3):947-51. PubMed ID: 19852934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Mol Pharm; 2010 Dec; 7(6):2148-55. PubMed ID: 20860349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.